COPD

News

Verona Pharma to trial lung drug ensifentrine for COVID-19

Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug companies repurposing their medicines to fight the pandemic.

News

AZ's COPD triple therapy approved in the US

AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the US following a re

News

Teva launches digital asthma and COPD rescue inhaler in US

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms.

News

Verona says FDA backs plan to take COPD drug into phase 3

More than two years after first saying it would take its lead drug into a pivotal trial, Verona Pharma looks like it may finally follow through on that promise.

News

FDA rejection scuppers AZ’s hopes of a COPD triple clash wit...

The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by

Views & Analysis

COPD: the world’s biggest neglected disease?

We speak to Verona Pharma’s CEO Jan-Anders Karlsson to find out how the company is looking to tackle the challenges of COPD, a surprisingly overlooked disease.

Verona Pharma to trial lung drug ensifentrine for COVID-19

AZ's COPD triple therapy approved in the US

Teva launches digital asthma and COPD rescue inhaler in US

Verona says FDA backs plan to take COPD drug into phase 3

FDA rejection scuppers AZ’s hopes of a COPD triple clash wit...

COPD: the world’s biggest neglected disease?

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

COPD

Editor's Picks